Ellomay Capital Ltd
ELLO
6 hedge funds and large institutions have $23.8M invested in Ellomay Capital Ltd in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
4% more capital invested
Capital invested by funds: $22.9M → $23.8M (+$916K)
0.26% more ownership
Funds ownership: 15.72% → 15.98% (+0.26%)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$433K |
| 2 |
JP Morgan Chase
New York
|
+$12.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$238 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$26.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.28K |
ELLO Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Ellomay Capital Ltd (ELLO) for Q3 2024, worth a combined $23.8M — up 4% from $22.9M a quarter earlier.
Fund positioning in ELLO was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Clal Insurance, adding an estimated $433K. The largest seller was Y.D. More Investments, cutting an estimated $26.3K.
- 6 institutional investors held Ellomay Capital Ltd (ELLO) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $23.8M of Ellomay Capital Ltd stock for Q3 2024, up 4% quarter-over-quarter.
- 1 fund opened new Ellomay Capital Ltd positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Ellomay Capital Ltd buyer in Q3 2024 was Clal Insurance, an estimated $433K added.
- The largest Ellomay Capital Ltd seller in Q3 2024 was Y.D. More Investments, an estimated $26.3K sold.
Based on aggregated 13F filings for Q3 2024.